- September 6, 2021
- Notice of Establishment of Overseas Offices in China (294KB)
- May 26, 2021
- Notice of Contract Manufacturing Agreement for Domestic Supply of AstraZeneca COVID-19 vaccine “Vaxzevria™ intramuscular injection” (160KB)
- May 17, 2021
- Acquisition of Shares of a Pharmaceutical Glass Container Manufacturing and Sales Company by a Nipro Overseas Subsidiary (354KB)
- April 26, 2021
- Acquisition of Shares of Changsha Bairong Dialysis Center and Shenyang Yizhiyuan Dialysis Center in China (192KB)
- Fraudulent Email Warning (27KB)
- October 6, 2021
- Annual Report
- September 9, 2021
- Publishment of NIPRO CORPORATION Social Finance Framework (496KB)
Issuance of Second Opinion by R&I (693KB) - August 17, 2021
- Corporate research report (Update notes) by Shared Research
- August 3, 2021
- Investor Relations Corporate research report (Full Report) by Shared Research
- This Web site has
introduced SSL encrypted
communication for the
privacy protection. 
